Most people with subclinical hypothyroidism don’t need medication. Treatment typically becomes necessary only when your TSH level rises above 10 mIU/L or when specific risk factors are present, such as thyroid antibodies or pregnancy. For everyone else, the standard approach is monitoring with repeat blood tests every 6 to 12 months.
Subclinical hypothyroidism means your TSH is elevated but your thyroid hormone levels (free T4) remain in the normal range. Your thyroid is underperforming slightly, enough to show up on a blood test but often not enough to cause noticeable symptoms. The key question is whether that mild elevation warrants treatment or watchful waiting.
When Medication Is Recommended
The clearest threshold for starting levothyroxine, the standard thyroid replacement hormone, is a TSH above 10 mIU/L. At that level, the risk of progressing to full hypothyroidism is high enough that most guidelines recommend treatment regardless of symptoms. The other trigger is a positive TPO (thyroid peroxidase) antibody test, which signals autoimmune thyroid disease. If your antibodies are elevated, treatment is generally recommended even with a lower TSH, because the autoimmune process tends to worsen over time.
If your TSH falls between roughly 4.5 and 10 mIU/L, you have no antibodies, and you feel fine, the evidence favors monitoring rather than medicating. Several large studies have failed to show meaningful benefit from levothyroxine in this group. You won’t typically see improved energy, mood, or cholesterol numbers from treating a mildly elevated TSH.
What Monitoring Looks Like
If your doctor recommends watching rather than treating, you’ll get your TSH rechecked every 6 to 12 months. This serves two purposes: confirming the initial reading wasn’t a temporary fluctuation, and catching any upward trend early. TSH can rise temporarily from illness, stress, or certain medications, so a single elevated result doesn’t always reflect a lasting thyroid problem.
During monitoring, pay attention to symptoms that might signal progression: persistent fatigue, unexplained weight gain, constipation, dry skin, feeling cold when others don’t, or brain fog. If these develop or worsen between blood tests, it’s worth getting rechecked sooner. The clinical situation, not just the calendar, determines when retesting makes sense.
Treatment During Pregnancy
Pregnancy changes the equation significantly. Your developing baby depends on your thyroid hormones during the first trimester, before its own thyroid gland becomes functional. The treatment thresholds are lower and the guidelines more aggressive.
A TSH above 10 mIU/L in the first trimester calls for treatment in all cases. For TSH between 2.5 and 10, the decision depends on your antibody status. If you test positive for TPO antibodies, treatment is recommended when TSH exceeds 4 and should be considered even between 2.5 and 4.0. If your antibodies are negative, treatment “may be considered” for TSH between 2.5 and 10, a weaker recommendation that leaves more room for clinical judgment. A TSH of 2.5 or below requires no treatment.
If you’re planning to become pregnant and already know you have subclinical hypothyroidism, getting your thyroid levels optimized beforehand is far simpler than adjusting mid-pregnancy.
Special Considerations for Older Adults
For people over 65, the risk-benefit balance tilts away from treatment in most cases. TSH naturally drifts upward with age, so a reading of 6 or 7 in an 80-year-old may simply reflect normal aging rather than a thyroid problem. The European Thyroid Association recommends using age-specific reference ranges, suggesting that a TSH of 4 to 7 mIU/L can be normal for people over 80.
One practical rule of thumb from the French Endocrine Society: divide your age by 10, and use that number as a rough upper limit of normal for TSH. By that measure, a TSH of 7.5 in a 75-year-old wouldn’t necessarily warrant treatment.
The bigger concern in older adults is overtreatment. Pushing TSH too low with levothyroxine can cause or worsen atrial fibrillation, reduce bone density, increase fracture risk, and raise overall mortality. Guidelines specifically warn against letting TSH drop below 0.1 mIU/L in older and postmenopausal women. When treatment is needed in this age group, the approach is to start at a low dose and increase slowly, with a higher TSH target of 4 to 6 mIU/L for people aged 70 to 80.
What Levothyroxine Treatment Involves
If you and your doctor decide on medication, the standard treatment is levothyroxine, a synthetic version of the T4 hormone your thyroid produces. For mild to moderate hypothyroidism, starting doses typically fall in the range of 50 to 75 micrograms daily, though the amount varies with body weight and the degree of TSH elevation. Young, otherwise healthy people may start closer to a full replacement dose of about 1.6 micrograms per kilogram of body weight per day.
You take it on an empty stomach, usually first thing in the morning, at least 30 to 60 minutes before eating. Calcium supplements, iron, and antacids can interfere with absorption, so those need to be spaced apart. After starting or adjusting your dose, you’ll typically get your TSH rechecked in 6 to 8 weeks to see whether the dose needs fine-tuning. Once stable, annual testing is usually sufficient.
Cardiovascular Benefits Are Limited
One common reason doctors consider treating subclinical hypothyroidism is its association with higher LDL cholesterol and cardiovascular risk. But the actual cardiovascular benefit of levothyroxine in this group has been disappointing in studies. Research consistently shows that treatment provides limited cardiovascular benefit, particularly in older adults, where the narrow therapeutic window increases the risk of side effects. Lowering your TSH with medication doesn’t reliably translate into fewer heart attacks or strokes for people with mild thyroid dysfunction.
This is one reason the threshold for treatment remains at TSH above 10 rather than at the first sign of elevation. Below that level, the expected benefits simply don’t outweigh the commitment of daily medication and the risks of overtreatment.
Selenium and Autoimmune Thyroid Disease
If your subclinical hypothyroidism is caused by Hashimoto’s thyroiditis (the autoimmune form, confirmed by positive TPO antibodies), selenium supplementation has some supporting evidence. Most studies have used 200 micrograms of selenium daily, typically as selenomethionine. The results show a significant reduction in TPO antibody levels at 3 months and 6 months, both in people taking levothyroxine and those who aren’t. However, the effect on TSH itself is not significant, meaning selenium may calm the autoimmune attack on your thyroid without directly improving thyroid function.
The benefit also appears to fade by 12 months in people not taking levothyroxine, raising questions about long-term value. Selenium is worth discussing with your doctor if you have autoimmune thyroid disease, but it isn’t a substitute for levothyroxine when medication is indicated. And because selenium can be toxic at high doses, more is not better.
Iodine: Getting Enough Without Overdoing It
Your thyroid needs iodine to produce hormones, and deficiency is a cause of hypothyroidism worldwide. For adults, the recommended daily intake is 150 micrograms (220 micrograms during pregnancy, 290 during breastfeeding). The tolerable upper limit for adults is 1,100 micrograms per day.
In countries where salt is iodized, most people get enough iodine without trying. The risk for people with thyroid issues is actually taking too much, often through kelp supplements or high-dose iodine products marketed for thyroid health. Excess iodine can paradoxically worsen hypothyroidism, especially in people with autoimmune thyroid disease. If you eat a varied diet that includes dairy, eggs, seafood, or iodized salt, you’re likely getting adequate iodine without supplementation.